Chlamydia trachomatis infection: Implications for HPV status and cervical cancer

Archives of Gynecology and Obstetrics

Volumn 289, Issue 4, 2014, Pages 715-723

  Silva, Jani ^a,b,c,d   Cerqueira, Fátima ^c,e   Medeiros, Rui ^a,c,d,e  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^d LPCC Research Department Portuguese League Against Cancer (LPCC NRN)   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cervical cancer; Chlamydia trachomatis; Human papillomavirus; Infection

Indexed keywords

ANTIGEN PRESENTING CELL; APOPTOSIS; CHLAMYDIASIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA REPLICATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; PAPILLOMAVIRUS INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL METAPLASIA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRAL CLEARANCE;

CARCINOGENESIS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84899005736     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3122-3     Document Type: Review

References (71)

1. WHO (1999) Estimated new cases of chlamydial infections among adults
2. ECDC (2011) Sexually transmitted infections in Europe, 1990-2009. ECDC, Stockholm
3. Paavonen J (2012) Chlamydia trachomatis infections of the female genital tract: state of the art. Ann Med 44(1):18-28. doi:10.3109/07853890.2010.546365
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer 127(12):2893-2917. doi:10.1002/ijc.25516
5. Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL (2009) Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 11(4):435-442. doi:10.1016/j.micinf.2009.01.004
6. Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjanen K, Ciotti M (2008) Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 51(4):230-234. doi:10.1159/000156481
7. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Eng J Med 327(18):1272-1278. doi:10.1056/NEJM199210293271804
8. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94(21):1604-1613. doi:10.1093/jnci/94.21.1604 (Pubitemid 35378725)
9. Gillet E, Meys JF, Verstraelen H, Verhelst R, De Sutter P, Temmerman M, Vanden Broeck D (2012) Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS One 7(10):e45201. doi:10.1371/journal.pone.0045201
10. Silins I, Ryd W, Stre A, Wadell G, Tornberg S, Hansson BG, Wang X, Arnheim L, Dahl V, Bremell D, Persson K, Dillner J, Ryleer E (2005) Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 116(1):110-115. doi:10.1002/ijc.20970 (Pubitemid 40827763)
11. Mylonas I (2012) Female genital Chlamydia trachomatis infection: where are we heading? Arch Gynecol Obstet 285(5):1271-1285. doi:10.1007/s00404-012- 2240-7
12. van de Laar MJ, Morre SA (2007) Chlamydia: a major challenge for public health. Euro Surveill 12(10):E1-E2
13. Markowska J, Fischer N, Filas V, Fischer Z, Breborowicz J, Markowski M (1999) The role of Chlamydia trachomatis infection in cervical cancer development. Eur J Gynaecol Oncol 20(2):144-146 (Pubitemid 29151460)
14. Markowska J, Fischer N, Fischer Z, Warchol JB (2002) Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. Eur J Gynaecol Oncol 23(6):511-513 (Pubitemid 36069992)
15. Zenilman JM (2001) Chlamydia and cervical cancer: a real association? JAMA 285(1):81-83. doi:10.1001/jama.285.1.81
16. Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4(4):221-233. doi:10.1158/1541-7786.MCR-05-0261
17. Multhoff G, Molls M, Radons J (2011) Chronic inflammation in cancer development. Front Immunol 2:98. doi:10.3389/fimmu.2011.00098
18. Matos A, Moutinho J, Pinto D, Medeiros R (2005) The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur J Cancer Prev 14(5):485-491 (pii): 00008469-200510000- 00007
19. Silva J, Cerqueira F, Ribeiro J, Sousa H, Osorio T, Medeiros R (2013) Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A self-sampling study. Arch Gynecol Obstet. doi:10.1007/s00404-013-2771-6
20. Al-Daraji WI, Smith JH (2009) Infection and cervical neoplasia: facts and fiction. Int J Clin Exp Pathol 2(1):48-64 PMC2491386
21. Silva J, Ribeiro J, Sousa H, Cerqueira F, Teixeira AL, Baldaque I, Osorio T, Medeiros R (2011) Oncogenic HPV types infection in adolescents and university women from North Portugal: from self-sampling to cancer prevention. J Oncol 2011:953469. doi:10.1155/2011/953469
22. Pista A, de Oliveira CF, Cunha MJ, Paixao MT, Real O (2012) Risk factors for human papillomavirus infection among women in Portugal: the CLEOPATRE Portugal study. Int J Gynaecol Obstet 118(2):112-116. doi:10.1016/j.ijgo.2012. 03.028
23. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7):453-459. doi:10.1016/S1473-3099(07)70158-5 (Pubitemid 46962343)
24. Franco EL, Duarte-Franco E, Ferenczy A (2001) Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164(7):1017-1025 (Pubitemid 34412231)
25. Castle PE, Giuliano AR (2003) Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients - assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 31:29-34
26. Hawes SE, Kiviat NB (2002) Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? J Natl Cancer Inst 94(21):1592-1593. doi:10.1093/jnci/94.21.1592 (Pubitemid 35378717)
27. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER (2005) Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162(7):668-675. doi:10.1093/aje/kwi262 (Pubitemid 41437366)
28. Beatty WL, Morrison RP, Byrne GI (1994) Persistent Chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58(4):686-699
29. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M (2001) An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10(10):1021-1027 (Pubitemid 32959148)
30. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF (1997) Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Investig 99(1):77-87. doi:10.1172/JCI119136 (Pubitemid 27058297)
31. de Sá AB, Gomes JP, Viegas S, Ferreira MA, Paulino A, MdA Catry (2002) Genital infection by Chlamydia trachomatis in Lisbon: prevalence and risk markers. Fam Pract 19(4):362-364. doi:10.1093/fampra/19.4.362 (Pubitemid 34846835)
32. Fischer N (2002) Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma. Eur J Gynaecol Oncol 23(3):247-250 PMID12094964
33. Byrne GI, Ojcius DM (2004) Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2(10):802-808. doi:10.1038/nrmicro1007 (Pubitemid 39317461)
34. Di Felice V, David S, Cappello F, Farina F, Zummo G (2005) Is chlamydial heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci 62(1):4-9. doi:10.1007/s00018-004-4367-6 (Pubitemid 40933087)
35. Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC (2003) Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol 189(5):1287-1292. doi:10.1067/S0002-9378(03)00755-5 (Pubitemid 37542159)
36. de Sanjose S, Munoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascunce N, Gonzalez LC, Tafur L, Gili M et al (1994) Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 56(3):358-363. doi:10.1002/ijc.2910560311 (Pubitemid 24087628)
37. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185(3):324-331. doi:10.1086/338569 (Pubitemid 34107245)
38. Matsumoto K, Yasugi T, Oki A, Hoshiai H, Taketani Y, Kawana T, Yoshikawa H (2003) Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies. Br J Cancer 89(5):831-833. doi:10.1038/sj.bjc.6601220 (Pubitemid 37175803)
39. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85(1):35-39. doi:10.1002/(SICI)1097-0215(20000101)85:1〈35:AID-IJC6〉3.0.CO;2-A
40. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, Van Den Brule AJ, Franceschi S, Peeling RW, study Imc- c (2004) Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111(3):431-439. doi:10.1002/ijc.20257 (Pubitemid 38998826)
41. Naucler P, Chen HC, Persson K, You SL, Hsieh CY, Sun CA, Dillner J, Chen CJ (2007) Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol 88(Pt 3):814-822. doi:10.1099/vir.0.82503-0 (Pubitemid 46359550)
42. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285(1):47-51. doi:10.1001/jama.285.1.47 (Pubitemid 32042715)
43. Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ, Wurscher M, Johnson LG, Galloway DA, Daling JR (2006) Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120(3):650-655. doi:10.1002/ijc.22325 (Pubitemid 44969037)
44. Jha PK, Beral V, Peto J, Hack S, Hermon C, Deacon J, Mant D, Chilvers C, Vessey MP, Pike MC et al (1993) Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 341(8853):1116-1118. doi:10.1016/0140-6736(93)93128-N (Pubitemid 23125855)
45. Munoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjose S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, Tafur L, Walboomers JM, Shah KV (1996) Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 23(6):504-510. doi:PMID8946637 (Pubitemid 26391576)
46. Quint KD, de Koning MN, Geraets DT, Quint WG, Pirog EC (2009) Comprehensive analysis of human papillomavirus and Chlamydia trachomatis in in situ and invasive cervical adenocarcinoma. Gynecol Oncol 114(3):390-394. doi:10.1016/j.ygyno.2009.05.013
47. Luostarinen T, Namujju PB, Merikukka M, Dillner J, Hakulinen T, Koskela P, Paavonen J, Surcel HM, Lehtinen M (2013) Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study. Int J Cancer. doi:10.1002/ijc.28173
48. Bosch FX, Castellsague X, Munoz N, de Sanjose S, Ghaffari AM, Gonzalez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, Guerrero E, Shah KV (1996) Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 88(15):1060-1067. doi:10.1093/jnci/88.15.1060 (Pubitemid 26260492)
49. Munoz N, Castellsague X, Bosch FX, Tafur L, de Sanjose S, Aristizabal N, Ghaffari AM, Shah KV (1996) Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 88(15):1068-1075. doi:10.1093/jnci/88.15.1068 (Pubitemid 26260493)
50. Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD (2010) Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst 102(23):1794-1804. doi:10.1093/jnci/djq436
51. Yokoyama M, Iwasaka T, Nagata C, Nozawa S, Sekiya S, Hirai Y, Kanazawa K, Sato S, Hoshiai H, Sugase M, Kawana T, Yoshikawa H (2003) Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan. Cancer Lett 192(2):171-179. doi:10.1016/S0304-3835(02) 00715-2 (Pubitemid 36369271)
52. Castle PE, Escoffery C, Schachter J, Rattray C, Schiffman M, Moncada J, Sugai K, Brown C, Cranston B, Hanchard B, Palefsky JM, Burk RD, Hutchinson ML, Strickler HD (2003) Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis 30(7):575-580. doi:10.1097/00007435-200307000-00009 (Pubitemid 36828983)
53. Ferrera A, Baay MF, Herbrink P, Figueroa M, Velema JP, Melchers WJ (1997) A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer 73(6):781-785. doi:10.1002/(SICI)1097-0215(19971210)73:6〈781:AID-IJC1〉3.0.CO;2-Z (Pubitemid 127483026)
54. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M (1996) Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 312(7030):537-539 PMC2350335
55. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, McPherson RS, Dorin MH (1994) Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271(15):1181-1188. doi:10.1001/jama.1994.03510390051029 (Pubitemid 24112998)
56. Wallin KL, Wiklund F, Luostarinen T, Angstrom T, Anttila T, Bergman F, Hallmans G, Ikaheimo I, Koskela P, Lehtinen M, Stendahl U, Paavonen J, Dillner J (2002) A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 101(4):371-374. doi:10.1002/ijc.10639 (Pubitemid 34987525)
57. Golijow CD, Abba MC, Mouron SA, Laguens RM, Dulout FN, Smith JS (2005) Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 96(1):181-186. doi:10.1016/j.ygyno.2004.09.037 (Pubitemid 39612434)
58. Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, Koutsky LA, Sings HL, Lu S, Haupt RM, Paavonen J, Future I, Group IIS (2011) Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect 87(5):372-376. doi:10.1136/sti.2010.044354
59. Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JL, Ortega L, Brown de Galaz EM, Stephan J, Feng J, Baldwin S, Garcia F, Hatch K (2001) Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 10(11):1129-1136 (Pubitemid 33064300)
60. Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P (2002) Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev 11(9):930-934 (Pubitemid 35014900)
61. Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, Nicosia R, Chiarini F, Antonelli G, Degener AM (2009) Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis 9:16. doi:10.1186/1471-2334-9-16
62. Gopalkrishna V, Aggarwal N, Malhotra VL, Koranne RV, Mohan VP, Mittal A, Das BC (2000) Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clin Microbiol Infec 6(2):88-93. doi:10.1046/j.1469-0691. 2000.00024.x (Pubitemid 36267448)
63. Finan RR, Tamim H, Almawi WY (2002) Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet 266(3):168-171. doi:10.1007/s00404-001- 0261-8 (Pubitemid 36056615)
64. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY (2002) Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 43(4):277-281. doi:10.1016/S0732-8893(02)00403-0 (Pubitemid 34874769)
65. Lehmann M, Groh A, Rodel J, Nindl I, Straube E (1999) Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus. J Infect 38(1):12-17. doi:10.1016/S0163-4453(99)90021-X (Pubitemid 29082010)
66. Molano M, Weiderpass E, Posso H, Morre SA, Ronderos M, Franceschi S, Arslan A, Meijer CJ, Munoz N, van den Brule AJ, Group HPVS (2003) Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia. Sex Transm Infect 79(6):474-478. doi:10.1136/sti.79.6.474 (Pubitemid 38021408)
67. da Silva CS, Adad SJ, Hazarabedian de Souza MA, Macedo Barcelos AC, Sarreta Terra AP, Murta EF (2004) Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. Gynecol Obstet Invest 58(4):189-193. doi:10.1159/000079822 (Pubitemid 39482655)
68. Giuliano AR, Papenfuss M, De Galaz EM, Feng J, Abrahamsen M, Denman C, De Zapien JG, Navarro Henze JL, Garcia F, Hatch K (2004) Risk factors for squamous intraepithelial lesions (SIL) of the cervix among women residing at the US-Mexico border. Int J Cancer 109(1):112-118. doi:10.1002/ijc.11656 (Pubitemid 38160670)
69. de Paula FDF, Fernandes AP, BBd Carmo, Vieira DCD, Dutra MS, CGMd Santos, MdCM Souza, Andrade TCA, Vago AR, Fernandes PÁ (2007) Molecular detection of Chlamydia trachomatis and HPV infections in cervical samples with normal and abnormal cytopathological findings. Diagn Cytopathol 35(4):198-202. doi:10.1002/dc.20629
70. Bhatla N, Puri K, Joseph E, Kriplani A, Iyer VK, Sreenivas V (2013) Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia - A pilot study. Indian J Med Res 137(3):533-539
71. GLOBOCAN Cancer Incidence and Mortality Worldwide (2008). http://globocan.iarc.fr/